Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1992 Oct 1;89(19):8884–8888. doi: 10.1073/pnas.89.19.8884

Inhibition of the self-renewal capacity of blast progenitors from acute myeloblastic leukemia patients by site-selective 8-chloroadenosine 3',5'-cyclic monophosphate.

A Pinto 1, D Aldinucci 1, V Gattei 1, V Zagonel 1, G Tortora 1, A Budillon 1, Y S Cho-Chung 1
PMCID: PMC50028  PMID: 1329084

Abstract

The physiologic balance between the two regulatory subunit isoforms, RI and RII, of cAMP-dependent protein kinase is disrupted in cancer cells; growth arrest and differentiation of malignant cells can be achieved when the normal ratio of these intracellular signal transducers of cAMP is restored by the use of site-selective cAMP analogs. In this study we evaluated the effects of the site-selective cAMP analog 8-chloroadenosine 3',5'-cyclic monophosphate (8-Cl-cAMP) on clonogenic growth of blast progenitors from 15 patients with acute myeloblastic leukemia and 3 patients affected by advanced myelodysplastic syndrome. Leukemic blast progenitors undergo terminal divisions, giving rise to colonies in methylcellulose. The self-renewal capacity of blast progenitors is conversely reflected in a secondary methylcellulose assay after exponential growth of clonogenic cells in suspension cultures. In all the samples tested, 8-Cl-cAMP, at micromolar concentrations (0.1-50 microM), suppressed in a dose-dependent manner both primary colony formation in methylcellulose and the recovery of clonogenic cells from suspension culture. Strikingly, in the samples from the entire group of patients, 8-Cl-cAMP was more effective in inhibiting the self-renewing clonogenic cells than the terminally dividing blast cells (P = 0.005). In addition, in four out of six cases studied, 8-Cl-cAMP was able to induce a morphologic and/or immunophenotypic maturation of leukemic blasts. An evident reduction of RI levels in fresh leukemic cells after exposure to 8-Cl-cAMP was also detected. Our results showing that 8-Cl-cAMP is a powerful inhibitor of clonogenic growth of leukemic blast progenitors by primarily suppressing their self-renewal capacity indicate that this site-selective cAMP analog represents a promising biological agent for acute myeloblastic leukemia therapy in humans.

Full text

PDF
8884

Images in this article

8887Image
on p.8887
8887Image
on p.8887

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ally S., Tortora G., Clair T., Grieco D., Merlo G., Katsaros D., Ogreid D., Døskeland S. O., Jahnsen T., Cho-Chung Y. S. Selective modulation of protein kinase isozymes by the site-selective analog 8-chloroadenosine 3',5'-cyclic monophosphate provides a biological means for control of human colon cancer cell growth. Proc Natl Acad Sci U S A. 1988 Sep;85(17):6319–6322. doi: 10.1073/pnas.85.17.6319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A., Gralnick H. R., Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med. 1985 Oct;103(4):620–625. doi: 10.7326/0003-4819-103-4-620. [DOI] [PubMed] [Google Scholar]
  3. Buick R. N., Chang L. J., Messner H. A., Curtis J. E., McCulloch E. A. Self-renewal capacity of leukemic blast progenitor cells. Cancer Res. 1981 Nov;41(11 Pt 2):4849–4852. [PubMed] [Google Scholar]
  4. Buick R. N., Minden M. D., McCulloch E. A. Self-renewal in culture of proliferative blast progenitor cells in acute myeloblastic leukemia. Blood. 1979 Jul;54(1):95–104. [PubMed] [Google Scholar]
  5. Cho-Chung Y. S., Clair T., Tortora G., Yokozaki H., Pepe S. Suppression of malignancy targeting the intracellular signal transducing proteins of cAMP: the use of site-selective cAMP analogs, antisense strategy, and gene transfer. Life Sci. 1991;48(12):1123–1132. doi: 10.1016/0024-3205(91)90449-l. [DOI] [PubMed] [Google Scholar]
  6. Cho-Chung Y. S., Clair T., Tortora G., Yokozaki H. Role of site-selective cAMP analogs in the control and reversal of malignancy. Pharmacol Ther. 1991;50(1):1–33. doi: 10.1016/0163-7258(91)90071-s. [DOI] [PubMed] [Google Scholar]
  7. Cho-Chung Y. S. Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: new approaches to therapy. Cancer Res. 1990 Nov 15;50(22):7093–7100. [PubMed] [Google Scholar]
  8. Cho-Chung Y. S. Site-selective 8-chloro-cyclic adenosine 3',5'-monophosphate as a biologic modulator of cancer: restoration of normal control mechanisms. J Natl Cancer Inst. 1989 Jul 5;81(13):982–987. doi: 10.1093/jnci/81.13.982. [DOI] [PubMed] [Google Scholar]
  9. Ciardiello F., Tortora G., Kim N., Clair T., Ally S., Salomon D. S., Cho-Chung Y. S. 8-Chloro-cAMP inhibits transforming growth factor alpha transformation of mammary epithelial cells by restoration of the normal mRNA patterns for cAMP-dependent protein kinase regulatory subunit isoforms which show disruption upon transformation. J Biol Chem. 1990 Jan 15;265(2):1016–1020. [PubMed] [Google Scholar]
  10. Curtis J. E., Messner H. A., Hasselback R., Elhakim T. M., McCulloch E. A. Contributions of host- and disease-related attributes to the outcome of patients with acute myelogenous leukemia. J Clin Oncol. 1984 Apr;2(4):253–259. doi: 10.1200/JCO.1984.2.4.253. [DOI] [PubMed] [Google Scholar]
  11. Døskeland S. O. Evidence that rabbit muscle protein kinase has two kinetically distinct binding sites for adenosine 3' ; 5'-cyclic monophosphate. Biochem Biophys Res Commun. 1978 Jul 28;83(2):542–549. doi: 10.1016/0006-291x(78)91024-0. [DOI] [PubMed] [Google Scholar]
  12. Koeffler H. P. Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood. 1983 Oct;62(4):709–721. [PubMed] [Google Scholar]
  13. Lu L., Welte K., Gabrilove J. L., Hangoc G., Bruno E., Hoffman R., Broxmeyer H. E. Effects of recombinant human tumor necrosis factor alpha, recombinant human gamma-interferon, and prostaglandin E on colony formation of human hematopoietic progenitor cells stimulated by natural human pluripotent colony-stimulating factor, pluripoietin alpha, and recombinant erythropoietin in serum-free cultures. Cancer Res. 1986 Sep;46(9):4357–4361. [PubMed] [Google Scholar]
  14. McCulloch E. A., Curtis J. E., Messner H. A., Senn J. S., Germanson T. P. The contribution of blast cell properties to outcome variation in acute myeloblastic leukemia (AML). Blood. 1982 Mar;59(3):601–608. [PubMed] [Google Scholar]
  15. McCulloch E. A. Regulatory mechanisms affecting the blast stem cells of acute myeloblastic leukemia. J Cell Physiol Suppl. 1986;4:27–33. doi: 10.1002/jcp.1041290407. [DOI] [PubMed] [Google Scholar]
  16. Minden M. D., Buick R. N., McCulloch E. A. Separation of blast cell and T-lymphocyte progenitors in the blood of patients with acute myeloblastic leukemia. Blood. 1979 Jul;54(1):186–195. [PubMed] [Google Scholar]
  17. Miyauchi J., Kelleher C. A., Wang C., Minkin S., McCulloch E. A. Growth factors influence the sensitivity of leukemic stem cells to cytosine arabinoside in culture. Blood. 1989 Apr;73(5):1272–1278. [PubMed] [Google Scholar]
  18. Miyauchi J., Kelleher C. A., Yang Y. C., Wong G. G., Clark S. C., Minden M. D., Minkin S., McCulloch E. A. The effects of three recombinant growth factors, IL-3, GM-CSF, and G-CSF, on the blast cells of acute myeloblastic leukemia maintained in short-term suspension culture. Blood. 1987 Sep;70(3):657–663. [PubMed] [Google Scholar]
  19. Nara N., Curtis J. E., Senn J. S., Tritchler D. L., McCulloch E. A. The sensitivity to cytosine arabinoside of the blast progenitors of acute myeloblastic leukemia. Blood. 1986 Mar;67(3):762–769. [PubMed] [Google Scholar]
  20. Nara N., McCulloch E. A. The proliferation in suspension of the progenitors of the blast cells in acute myeloblastic leukemia. Blood. 1985 Jun;65(6):1484–1493. [PubMed] [Google Scholar]
  21. Nara N., Suzuki T., Nagata K., Yamashita Y., Murohashi I., Adachi Y. Relationship between the in vitro sensitivity to cytosine arabinoside of blast progenitors and the outcome of treatment in acute myeloblastic leukaemia patients. Br J Haematol. 1988 Oct;70(2):187–191. doi: 10.1111/j.1365-2141.1988.tb02462.x. [DOI] [PubMed] [Google Scholar]
  22. Nara N., Suzuki T., Yamashita Y., Murohashi I., Aoki N. Cytotoxicity of 4-hydroperoxycyclophosphamide for the blast progenitors of acute myeloblastic leukemia. Cancer Res. 1988 May 1;48(9):2348–2352. [PubMed] [Google Scholar]
  23. Nara N., Tohda S., Nagata K., Suzuki T., Yamashita Y. Inhibition of the in vitro growth of blast progenitors from acute myeloblastic leukemia patients by transforming growth factor-beta (TGF-beta). Leukemia. 1989 Aug;3(8):572–577. [PubMed] [Google Scholar]
  24. Ogreid D., Ekanger R., Suva R. H., Miller J. P., Sturm P., Corbin J. D., Døskeland S. O. Activation of protein kinase isozymes by cyclic nucleotide analogs used singly or in combination. Principles for optimizing the isozyme specificity of analog combinations. Eur J Biochem. 1985 Jul 1;150(1):219–227. doi: 10.1111/j.1432-1033.1985.tb09010.x. [DOI] [PubMed] [Google Scholar]
  25. Pinto A., Colletta G., Del Vecchio L., Rosati R., Attadia V., Cimino R., Colombatti A. c-fos oncogene expression in human hematopoietic malignancies is restricted to acute leukemias with monocytic phenotype and to subsets of B cell leukemias. Blood. 1987 Nov;70(5):1450–1457. [PubMed] [Google Scholar]
  26. Rannels S. R., Corbin J. D. Two different intrachain cAMP binding sites of cAMP-dependent protein kinases. J Biol Chem. 1980 Aug 10;255(15):7085–7088. [PubMed] [Google Scholar]
  27. Salem M., Delwel R., Touw I., Mahmoud L., Löwenberg B. Human AML colony growth in serum-free culture. Leuk Res. 1988;12(2):157–165. doi: 10.1016/0145-2126(88)90076-8. [DOI] [PubMed] [Google Scholar]
  28. Tortora G., Clair T., Katsaros D., Ally S., Colamonici O., Neckers L. M., Tagliaferri P., Jahnsen T., Robins R. K., Cho-Chung Y. S. Induction of megakaryocytic differentiation and modulation of protein kinase gene expression by site-selective cAMP analogs in K-562 human leukemic cells. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2849–2852. doi: 10.1073/pnas.86.8.2849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Tortora G., Tagliaferri P., Clair T., Colamonici O., Neckers L. M., Robins R. K., Cho-Chung Y. S. Site-selective cAMP analogs at micromolar concentrations induce growth arrest and differentiation of acute promyelocytic, chronic myelocytic, and acute lymphocytic human leukemia cell lines. Blood. 1988 Jan;71(1):230–233. [PubMed] [Google Scholar]
  30. Wang C., McCulloch E. A. Sensitivity to 5-azacytidine of blast progenitors in acute myeloblastic leukemia. Blood. 1987 Feb;69(2):553–559. [PubMed] [Google Scholar]
  31. Welte K., Platzer E., Lu L., Gabrilove J. L., Levi E., Mertelsmann R., Moore M. A. Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Proc Natl Acad Sci U S A. 1985 Mar;82(5):1526–1530. doi: 10.1073/pnas.82.5.1526. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES